O'Connor Kevin J. 4
4 · Encompass Health Corp · Filed Apr 16, 2026
Research Summary
AI-generated summary of this filing
Encompass Health Director Kevin J. O'Connor Receives RSU Award
What Happened
- Kevin J. O'Connor, a director of Encompass Health Corp (EHC), was credited with an award of 17 restricted stock units (RSUs) on 2026-04-15. The Form 4 reports an acquisition price of $0.00 for these 17 RSUs; at the closing price on the dividend payment date ($105.24), the award had an approximate market value of $1,789.08.
- This was an award (transaction code A), not an open-market purchase or sale.
Key Details
- Transaction date: 2026-04-15; Form 4 filed: 2026-04-16 (timely filing).
- Reported transaction: 17 RSUs acquired at $0.00.
- Approximate market value at closing price $105.24: 17 × $105.24 = $1,789.08.
- Shares owned after transaction: not disclosed in this filing.
- Footnote: The RSUs were credited under existing director RSU award agreements in connection with Encompass Health’s dividend payment. The April 15, 2026 dividend was $0.19 per share; the number of RSUs credited is based on a formula using the dividend and the closing price (see footnote F1).
Context
- This transaction reflects dividend-equivalent RSUs being credited to a non-employee director’s account — a routine, non-cash award tied to the company’s dividend policy rather than a buy or sell decision by the director.
- Awards like this are common for directors who elect to receive dividends in the form of additional RSUs; they do not by themselves indicate a change in insider sentiment.
Insider Transaction Report
Form 4
O'Connor Kevin J.
Director
Transactions
- Award
Encompass Health Common Stock
[F1]2026-04-15+17→ 9,929 total
Footnotes (1)
- [F1]Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments, The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 15, 2026, Encompass Health paid a dividend on its common stock of $0.19 per share and the closing price was $105.24. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.
Signature
/s/ Patrick Darby, attorney-in-fact for Kevin J. O'Connor|2026-04-16